NetworkNewsBreaks – Odyssey Health Inc. (ODYY) P
Post# of 85
(Total Views: 151)
Posted On: 07/07/2022 5:06:40 PM
NetworkNewsBreaks – Odyssey Health Inc. (ODYY) Poised to Successfully Commercialize Its Products
Odyssey Health (OTC: ODYY) is a Nevada-based medical company developing a variety of drug and technology assets to treat unmet clinical needs. “Odyssey is dedicated to advancing life-saving medical products that offer similar levels of hope to a new generation of people through technological and clinical developments that demonstrate advantages over current standards of care. At the moment, Odyssey’s market profile includes two medical device candidates and two pharmaceutical products in development. The portfolio is responding to varied needs, including patients who may have undiagnosed heart disease, patients choking on some type of obstruction lodged in their throats, patients dealing with a rare neurodegenerative disorder, and patients needing treatment for brain concussion injuries,” a recent article reads. “CEO Michael Redmond spoke with The RedChip Money Report(R) on Bloomberg TV to explain the company’s model… ‘They have strong IP positions – on all three of them,’ Redmond said [of the company’s drug-device combination for treating concussion, a cardiological prototype device, and an anti-choking device]. ‘We believe that we have the management, the board of directors, and the experience level … that will allow us to successfully commercialize all three of these products and create significant value for the company.’”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Odyssey Health (OTC: ODYY) is a Nevada-based medical company developing a variety of drug and technology assets to treat unmet clinical needs. “Odyssey is dedicated to advancing life-saving medical products that offer similar levels of hope to a new generation of people through technological and clinical developments that demonstrate advantages over current standards of care. At the moment, Odyssey’s market profile includes two medical device candidates and two pharmaceutical products in development. The portfolio is responding to varied needs, including patients who may have undiagnosed heart disease, patients choking on some type of obstruction lodged in their throats, patients dealing with a rare neurodegenerative disorder, and patients needing treatment for brain concussion injuries,” a recent article reads. “CEO Michael Redmond spoke with The RedChip Money Report(R) on Bloomberg TV to explain the company’s model… ‘They have strong IP positions – on all three of them,’ Redmond said [of the company’s drug-device combination for treating concussion, a cardiological prototype device, and an anti-choking device]. ‘We believe that we have the management, the board of directors, and the experience level … that will allow us to successfully commercialize all three of these products and create significant value for the company.’”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Odyssey Group Intl Inc (ODYY) Stock Research Links
Scroll down for more posts ▼